Accreditation Statements
FungalDx26
December 2–4, 2026 (A Hybrid Event)
Bethesda, MD, USA & Online
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of International Institute for Continuing Medical Education and the Fungal Diagnostics Working Group of the ISHAM. International Institute for Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
International Institute for Continuing Medical Education designates the hyrbid format for this educational activity for a maximum of 22.00 AMA PRA Category 1 Credits™.
Hybrid activity dates: December 2, 2026 – December 4, 2026
Enduring activity dates: January 15, 2027– January 15, 2028
International Institute for Continuing Medical Education designates the enduring format for this educational activity for a maximum of 22.00 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Registered Nurses: The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME. Visit the ANCC’s website for more information.
Pharmacists: Different state boards of pharmacy have different requirements for continuing education. Some accept CME credit, while others accept only ACPE-approved CPE (continuing pharmacy education) credit.
Please refer to your state board of pharmacy to find out if CME is accepted. Please note that all final decisions about credit hour acceptance will be made by the licensing organization to which the credit hours are submitted.
Physician Assistants: NCCPA accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.
iiCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity. This activity may include discussion of investigational or off-label uses of products or devices. International Institute for Continuing Medical Education does not endorse or promote the use of any product or device outside of its approved indications.
Artificial Intelligence (AI) Use Disclosure
In accordance with the standards and guidance set forth by the Accreditation Council for Continuing Medical Education (ACCME), individuals in control of content are required to disclose the use of artificial intelligence (AI) in the development of educational materials. This includes identification of the specific AI tool(s) utilized and a description of how AI contributed to content creation.
iiCME maintains oversight of all educational content and conducts a thorough review process to ensure that materials are evidence-based, fair-balanced, and free from commercial bias, consistent with ACCME Standards for Integrity and independence.
While AI may be used as a supportive tool in content development, it does not replace clinical expertise or independent medical judgment. Learners are advised to critically evaluate all information presented and apply their own professional judgment when incorporating knowledge into clinical practice.